Michigan Medicine 11th Annual Western Michigan Liver Round-Up 2022

Michigan Medicine 11th Annual Western Michigan Liver Round-Up Join us on Friday, October 14 for a hybrid program (in-person or virtual option). New information regarding the evaluation and management of patients with hepatic steatosis and alcoholic liver disease will be presented. Case-based discussions on the current approach to patients with checkpoint inhibitor hepatotoxicity and fatty liver disease will also be presented

• Include: 7 videos + 1 pdf, size: 984 MB

Target Audience: gastroenterologist, primary care physican

Sample video: contact me for sample video

Information:

Description

Join us on Friday, October 14 for a hybrid program (in-person or virtual option). New information regarding the evaluation and management of patients with hepatic steatosis and alcoholic liver disease will be presented. Case-based discussions on the current approach to patients with checkpoint inhibitor hepatotoxicity and fatty liver disease will also be presented.

Target Audience

This activity is appropriate for:

House Officers, Medical Students, Nurse Practitioners, Nurses, Other Healthcare Professionals, Physician Assistants, Physicians

In the fields of:

Family Medicine, Gastroenterology, General Medicine, Hepatology, Internal Medicine, Primary Care, Transplant Surgery

Learning Objectives

At the end of this activity, participant will understand and be able to implement:

• Latest developments in the management of nonalcoholic fatty liver disease (NAFLD) including insulin sensitizing agent
• Use of anti-craving agents and cognitive behavioral therapy in alcoholic liver disease (ALD) patient
• Information regarding the safety and efficacy of herbal products commonly used by patients with liver disease
• Up to date information on the role of albumin and terlipressin in the management of hepatorenal syndrome (HRS)
• Role of the microbiome and modern diagnostic approaches to hepatic encephalopathy
• Latest updates on proposed models to improve liver allocation in the US for liver transplant candidates

Topics:

• 11thannualWesternliverroundup080122_0801_135741.pdf
• Diagnosis and Treatment of Alcohol Use Disorder (AUD) in Alcohol Liver Disease (ALD).ts
• Herbs and the Liver The Good, Bad, and Ugly.ts
• Medical Management of Patients with NAFLD.ts
• Modern Approaches to Hepatic Encephalopathy Diagnosis and Management.ts
• Panel Question & Answers.ts
• Terlipressin and Albumin in Cirrhotics with Acute Kidney Injury.ts
• Updates on Liver Allocation and Transplantation.ts